Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Eur J Clin Microbiol Infect Dis ; 41(10): 1237-1243, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36056207

ABSTRACT

We conducted a retrospective study from 2005 to 2019 to describe the epidemiology and mortality of enterobacterial producing extended-spectrum ß-lactamase (E-ESBL) infections in our university hospital over a 17-year period of time. Clinical and microbiological data were extracted from different software used for continuous surveillance. Stool samples from systematic screening for E-ESBL colonization were excluded from the study. The incidence rate of infected patient was calculated by E-ESBL species and by year. A comparison of mortality rate in patients with bloodstream infections versus other types of infections was conducted using a Kaplan-Meier method survival curves. A log rank test (with a risk of 5%) was carried out. A total of 3324 patients with E-ESBL infection were included with an increased incidence density per 1000 days of hospitalization from 0.03 in 2005 to 0.47 in 2019. Escherichia coli was the most frequently isolated pathogen (64%). Global mortality rate was significantly higher with E. coli than with Klebsiella spp. and Enterobacter spp. (p < 0.001). Mortality was higher in patients with E-ESBL bloodstream infection than in patients with other type of E-ESBL infection (p < 0.001). Our study showed a significant increase of the E-ESBL incidence density over a 17-year period survey with a higher mortality in patients with E-ESBL bacteremia. This highlights the need to continue efforts to control the spread of these multi-resistant bacteria in our institution.


Subject(s)
Bacteremia , Enterobacteriaceae Infections , Escherichia coli Infections , Anti-Bacterial Agents/therapeutic use , Bacteremia/microbiology , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/epidemiology , Escherichia coli , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Humans , Incidence , Klebsiella , Retrospective Studies , Risk Factors , beta-Lactamases
2.
3.
Int J Hyg Environ Health ; 211(3-4): 403-11, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17720622

ABSTRACT

We developed a quantitative real-time PCR assay targeting the mip gene of Legionella pneumophila for a prospective study from September 2004 to April 2005. It was compared with a standard culture method (French guideline AFNOR T90-431), analysing 120 water samples collected to monitor the risk related to Legionellae at Nantes hospital and to investigate a case of legionellosis acquired from hospital environment. Samples from six distinct water distribution systems were analysed by DNA extraction, amplification and detection with specific primers and FRET probes. The detection limit was 100 genomic units of L. pneumophila per liter (GU/l), the positivity threshold about 600 GU/l and the quantification limit 800 GU/l. PCR results were divided into three groups: negative (n=63), positive but non-quantifiable (n=22) or positive (n=35). PCR showed higher sensitivity than culture, whereas four culture-positive samples appeared negative by PCR (PCR inhibitor detected for two of them). Although no correlation was observed between both methods and real-time PCR cannot substitute for the reference method, it represents an interesting complement. Its sensitivity, reproducibility and rapidity appear particularly interesting in epidemic contexts in order to identify the source of contamination or to evaluate critical points of contamination in water distribution systems.


Subject(s)
Legionella pneumophila/isolation & purification , Polymerase Chain Reaction/methods , Water Microbiology , Water Supply/analysis , Aged , Bacterial Proteins/genetics , Colony Count, Microbial , Cross Infection/microbiology , Cross Infection/prevention & control , Culture Techniques , DNA Probes , DNA, Bacterial/isolation & purification , Disease Outbreaks/prevention & control , France , Hospitals , Humans , Legionella pneumophila/genetics , Legionnaires' Disease/microbiology , Legionnaires' Disease/prevention & control , Male , Peptidylprolyl Isomerase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...